Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Fisher & Paykel Healthcare's Enterprise Value is A$18,221 Mil.
Fisher & Paykel Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was A$552 Mil. Therefore, Fisher & Paykel Healthcare's EV-to-EBIT ratio for today is 33.03.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Fisher & Paykel Healthcare (ASX:FPH) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Fisher & Paykel Healthcare's EV-to-EBIT for today is
Fisher & Paykel Healthcare's current Enterprise Value is A$18,221 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was A$552 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Fisher & Paykel Healthcare's EV-to-EBITDA for today is:
Fisher & Paykel Healthcare's current Enterprise Value is A$18,221 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was A$688 Mil.
Fisher & Paykel Healthcare's current Enterprise Value is A$18,221 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was A$1,988 Mil.
Fisher & Paykel Healthcare's current Enterprise Value is A$18,221 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was A$567 Mil.
Fisher & Paykel Healthcare's current Enterprise Value is A$18,221 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was A$401 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fisher & Paykel Healthcare Enterprise Value Related Terms
Fisher & Paykel Healthcare Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:FPH vs ISRG, BDX, MDLN: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's Enterprise Value falls into.
Fisher & Paykel Healthcare Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Fisher & Paykel Healthcare's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of A$18,221 Mil mean?
Fisher & Paykel Healthcare (ASX:FPH) has a Enterprise Value of A$18,221 Mil as of Jun. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Fisher & Paykel Healthcare and its competitors.
Is Fisher & Paykel Healthcare's Enterprise Value too high?
Fisher & Paykel Healthcare's current Enterprise Value is A$18,221 Mil. Overall, Fisher & Paykel Healthcare has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Enterprise Value compare to ISRG and BDX?
Fisher & Paykel Healthcare's Enterprise Value of A$18,221 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Fisher & Paykel Healthcare and its competitors. Fisher & Paykel Healthcare's current Enterprise Value is A$18,221 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (ASX:FPH) is currently considered Modestly Undervalued. The stock's GF Value™ is A$36.31, compared to a current price of A$31.57 — trading 13.1% below its estimated fair value. The current Enterprise Value is A$18,221 Mil. Fisher & Paykel Healthcare's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Fisher & Paykel Healthcare (ASX:FPH), the current Enterprise Value is A$18,221 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fisher & Paykel Healthcare (ASX:FPH) Overvalued in 2026?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued.
The current stock price of A$31.57 is trading 13.1% below its estimated GF Value™ of A$36.31.
GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.
Key valuation signals for ASX:FPH:
Enterprise Value: A$18,221 Mil
GF Value™: A$36.31 vs. price of A$31.57 (13.1% below fair value)
No single metric tells the full story. See the ASX:FPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
88GF Score
Get the complete analysis for ASX:FPH
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:FPH has been successfully added to your 
